Zang et al., 2018 - Google Patents
Serum adropin levels are decreased in Chinese type 2 diabetic patients and negatively correlated with body mass indexZang et al., 2018
View PDF- Document ID
- 7936336667071775984
- Author
- Zang H
- Jiang F
- Cheng X
- Xu H
- Hu X
- Publication year
- Publication venue
- Endocrine journal
External Links
Snippet
Adropin has been identified as potent regulatory hormone implicated in insulin sensitivity and the maintenance of energy homeostasis. The aim of current study was to investigate serum adropin concentrations of type 2 diabetes mellitus (T2DM) patients in the fasting …
- 101700064116 ENHO 0 title abstract description 122
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/412—Detecting or monitoring sepsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zang et al. | Serum adropin levels are decreased in Chinese type 2 diabetic patients and negatively correlated with body mass index | |
| Jones et al. | Plasma lactate as a marker of metabolic health: Implications of elevated lactate for impairment of aerobic metabolism in the metabolic syndrome | |
| Wang et al. | Serum levels of meteorin-like (Metrnl) are increased in patients with newly diagnosed type 2 diabetes mellitus and are associated with insulin resistance | |
| Lee et al. | Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults | |
| Simon et al. | Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis | |
| Leehey et al. | Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study | |
| Suleymanoglu et al. | Vaspin and its correlation with insulin sensitivity indices in obese children | |
| Obata et al. | Relationship between serum adiponectin levels and age in healthy subjects and patients with type 2 diabetes | |
| Xu et al. | Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese | |
| Yan et al. | Decreased plasma neuregulin 4 levels are associated with peripheral neuropathy in Chinese patients with newly diagnosed type 2 diabetes: a cross-sectional study | |
| Sente et al. | Tumor necrosis factor-α impairs adiponectin signalling, mitochondrial biogenesis, and myogenesis in primary human myotubes cultures | |
| Wlazlo et al. | Low-grade inflammation and insulin resistance independently explain substantial parts of the association between body fat and serum C3: the CODAM study | |
| Huang et al. | Insulin resistance, hyperglycemia, and risk of developing obstructive sleep apnea in men and women in the United States | |
| Onalan et al. | Low serum levels of meteorin-like/subfatin: an indicator of diabetes mellitus and insulin resistance? | |
| Moesgaard et al. | Effects of breed, gender, exercise and white-coat effect on markers of endothelial function in dogs | |
| Polat et al. | The relationship between frailty and serum alpha klotho levels in geriatric patients | |
| Banu et al. | C-peptide and its correlation to parameters of insulin resistance in the metabolic syndrome | |
| Mancuso et al. | Effects of Alpha-2-HS-glycoprotein on cognitive and emotional assessment in prediabetic and diabetic subjects | |
| Taner et al. | The value of serum asymmetric dimethylarginine levels for the determination of masked hypertension in patients with diabetes mellitus | |
| Xu et al. | Serum advanced glycation end products are associated with insulin resistance in male nondiabetic patients with obstructive sleep apnea | |
| Meral et al. | New adipocytokines (vaspin, apelin, visfatin, adiponectin) levels in children treated with valproic acid | |
| Chuang et al. | The relationships between hematogram and metabolic syndrome in elderly subgroups: a Taiwan cohort study | |
| Uzunlulu et al. | Cut-off values for waist circumference in Turkish population: is there a threshold to predict insulin resistance | |
| Hong et al. | The effect of physical activity on serum IL-6 and vaspin levels in late elementary school children | |
| US7592180B2 (en) | Method for evaluating insulin resistance |